Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Terms Are Improving. More details...
CBT 200 Gains 62 Points. More details...
CBT 200 Adds On 23 Points Today. More details...
CBT 200 Up Almost 4%. More details...
Shanghai Sunway To Market Copycat Therapy. More details...
Biotech Industry Fought Hard But Lost. More details...
Biotech Virtually Flat Today. More details...
Will Abgenix Site Be New Home Of Amgen-San Francisco?....
CBT 200 Gains 28 Points. More details...
CBT 200 Takes A Small Loss. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
